TREPROSTINILFORMULIERUNGEN

Patent europeic · EP3164155 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3164155
Numer da la dumonda
EP15731463
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
12-06-2015
Publitgà
10-05-2017
Concedì
09-02-2022
Stritgà
25-01-2023
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 47/32 (2006.01)
A61K 9/14 (2006.01)
A61K 31/557 (2006.01)
A61K 9/10 (2006.01)
A61P 9/12 (2006.01)
Prioritad
US 201462011689 P 13.06.2014
Dumonda PCT
PCT/US2015/035595 12.06.2015
Publicaziun PCT
WO2015/192030 17.12.2015
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 25-01-2023

    Stritgà, taxa betg pajada

    Published in Swissreg on 25.01.2023

  2. 21-12-2022

    Midada

    Published in Swissreg on 21.12.2022

  3. 09-02-2022

    Concedì

    Published in Swissreg on 09.02.2022

Partidas

Possessur

United Therapeutics Corporation

1040 Spring Street, Silver Spring, MD 20910, US

Inventur

PHARES, Ken

Hillborough, North Carolina 27278, US

CHANG, Courtney

Raleigh, North Carolina 27617, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.